Patents Examined by Tiffany Gough
  • Patent number: 9365884
    Abstract: An environmental evaluation installation including an evaluation chamber 1 isolated from outer space by isolation walls 2, minute substance supply means 3 configured to supply a microorganism into the evaluation chamber 1, a minute substance removing means 4 configured to supply removal particles for removing the microorganism into the evaluation chamber 1, and a minute substance collecting means 5 configured to collect the microorganism in the evaluation chamber 1, and which is characterized in that many air supply holes 21 are provided for almost the whole surfaces of the isolation walls 2 except at least the floor surface of the isolation walls 2 and that air is made to flow into the evaluation chamber 1 from the air supply holes 21.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: June 14, 2016
    Assignee: SHARP KABUSHIKI KAISHA
    Inventors: Kazuo Nishikawa, Norihiro Matsuoka, Tetsuya Yoneda, Hisaharu Yagi, Masashi Kawai
  • Patent number: 9365822
    Abstract: Improved flow cytometer system particularly adapted to use for sex-selected sperm sorting include enhanced sheath fluid and other strategies which minimize stress on the sperm cells, including a 2.9 percent sodium citrate sheath solution for bovine species and a hepes bovine gamete media for equine species. Improved collection systems and techniques for the process are described so that commercial applications of sperms samples as well as the resulting animals may be achieved.
    Type: Grant
    Filed: February 11, 2013
    Date of Patent: June 14, 2016
    Assignee: XY, LLC
    Inventors: George E. Seidel, Lisa A. Herickhoff, John L. Schenk
  • Patent number: 9341618
    Abstract: The present invention provides a method for evaluating or screening a hair growth-regulating agent which utilizes a readily available animal. The present invention is directed to a method for evaluating or screening a hair growth-regulating agent which comprises subjecting hair follicles of a pig to an organ culture in the presence of a test substance, and evaluating or selecting a substance which promotes or suppresses the growth of the hair follicles.
    Type: Grant
    Filed: February 19, 2008
    Date of Patent: May 17, 2016
    Assignee: Kao Corporation
    Inventors: Michiyo Sasajima, Noriko Ito, Shigeru Moriwaki, Chie Fuse
  • Patent number: 9309552
    Abstract: The present invention concerns a method for specifically detecting and identifying Streptococcus agalactiae, using a reaction medium comprising at least one esterase enzymatic substrate.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: April 12, 2016
    Assignee: BIOMERIEUX
    Inventors: Laurence Barbaux, Denis Robichon
  • Patent number: 9273285
    Abstract: The present disclosure provides a method of determining the frequency and proliferative potential of progenitor cells in a starting cell preparation comprising (a) culturing the cell preparation for 5-10 days in a culture medium comprising FLT-3 Ligand (FL) and Thrombopoietin (TPO); (b) detecting and enumerating the colonies; and (c) assessing the frequency and proliferative potential of progenitor cells in the starting cell preparation based on the number of colonies in step (b). The number of colonies in step (b) correlates to the number of colonies in a standard 14-day colony-forming cell assay. The method is particularly useful for predicting and evaluating the suitability of grafts for transplantation.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: March 1, 2016
    Assignee: STEMCELL TECHNOLOGIES INC.
    Inventors: Albertus W. Wognum, Ning Yuan
  • Patent number: 9255926
    Abstract: The present invention provides methods of classifying cluster of differentiation (CD) marker phenotype for hematopoietic cancer cells using multiple circulating cell-free CD markers in bodily fluid. In other aspects, treatment and disease progression of particular hematopoietic cancers can be monitored by measuring the levels of CD and other markers i bodily fluids of a patient.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: February 9, 2016
    Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventor: Maher Albitar
  • Patent number: 9229011
    Abstract: The present invention relates to methods of diagnosing, predicting and monitoring kidney disorders. In particular, the present invention relates to the diagnosis, prediction and monitoring of kidney disorders by detection of cytokines, cytokine-related compounds and chemokines in urine. The present invention further relates to methods and compositions for assessing the efficacy of agents and interventions used to treat kidney disorders.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: January 5, 2016
    Assignee: RENOVAR INCORPORATED
    Inventors: Huaizhong Hu, Stuart Knechtle
  • Patent number: 9211308
    Abstract: Provided are ejaculum of animals as medicinal materials and uses thereof in manufacture of medicaments for treatment of various tumors, depression, senile dementia, and dermatosis. Said tumors include ovarian cancer, uterine cancer, breast cancer, esophageal cancer, stomach cancer, colon cancer, lung cancer, osteocarcinama, etc. The present medicinal material, alone or in combination with additional agents, is similar to cyclophosphamide in antineoplastic effects, which is accepted presently the most potent chemotherapeutic agent. It can inhibit the growth of tumors, not destroying the normal immune system of human. The present medicinal material of ejaculum is powdery crystal prepared by vacuum lyophilization from fresh ejaculum of animals, and it is suitable to a variety of dosage forms such as capsule or oral solution.
    Type: Grant
    Filed: March 24, 2008
    Date of Patent: December 15, 2015
    Inventor: Yan Li
  • Patent number: 9176120
    Abstract: The invention provides serum-based, diagnostic, biological assays for predicting disorders of pregnancy resulting from poor trophoblast and/or placental ischemia, including preeclampsia. Serum samples from such subjects exhibit an ability to disrupt the architecture involving fetal trophoblasts and maternal endothelial cells in a three-dimensional, dual cell co-culture system provided herein, in contrast to normal pregnancy serum samples. Based on these distinctions, the assays are employed to predict pregnancy outcomes as early as first trimester.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: November 3, 2015
    Assignee: WOMEN & INFANTS' HOSPITAL OF RHODE ISLAND
    Inventors: Surendra Sharma, Satyan Kalkunte
  • Patent number: 9161901
    Abstract: A method of delivering a compound of interest to the lungs of a subject by the intravenous injection of Sertoli cells loaded with a plurality of chitosan nanoparticles coupled with the compound of interest is provided. Testis-derived rat Sertoli cells were pre-loaded with chitosan nanoparticles coupled with or without the drug curcumin, pre-labeled with a fluorescent cell marker and then injected intravenously into the control or asthmatic mouse model host. Intact pre-loaded, pre-labeled Sertoli cells were present in the lungs at 15 minutes post-injection, appeared entrapped in the pulmonary pre-capillary vascular bed around alveolar sacs but were not present one hour post-injection although Sertoli cell label and cellular debris was. Most of the injected nanoparticle load (70%) and curcumin load (80%) was present in the lungs 15 minutes post-injection, and remained at 70% and 80%, respectively, one hour post-injection.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: October 20, 2015
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Arun Kumar, Shyam S. Mohapatra, Don F. Cameron
  • Patent number: 9157063
    Abstract: The present invention includes methods and apparatus to separate X or Y-chromosome bearing sperm cells in a population by first placing the population of sperm cells at physiological pH environment, and simultaneously contacting the population of sperm cells with one or more additional sub-environments with different pH values. The exposure allows mobile sperm cells bearing X or Y-chromosome to migrate to the different pH sub-environments, wherein each cell only exposed or come in contact with one pH sub-environment. Finally, the collecting X or Y-chromosome enriched population of sperm cells is performed.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: October 13, 2015
    Assignee: Texas Tech University System
    Inventors: Samuel D. Prien, Lindsay L. Penrose
  • Patent number: 9107402
    Abstract: A composition and method is provided to modify sperm fertility and sex ratio of mammalian offspring. The composition includes an amount of a class of compounds of phenoxazine or phenothiazine, having the structure (see FIG. 1) and ionic derivatives thereof, wherein R1 is H, a lower alkyl group or N (R3)2, R2 is N, S, O, and R3 is H or a lower alkyl group. A second component of the composition is an amount of an electron transfer agent capable of oxidizing a reduced cofactor (NADPH or NADH). A third component of the composition is an amount of a hexose sugar and/or the phosphorylated esters of such. When mixed with living sperm prior to or at the time of insemination, the composition results in modified rates of conception and an alteration of birth sex ratio.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: August 18, 2015
    Inventor: Timothy James Williams
  • Patent number: 9110078
    Abstract: Methods for diagnosing pathology of the liver in subject suspected of having such pathology by measuring the glycosylation of anti-gal IgG in various biological fluids of the subject.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: August 18, 2015
    Assignee: Drexel University
    Inventors: Timothy M. Block, Mary Ann Comunale, Anand Mehta
  • Patent number: 9097693
    Abstract: The invention provides a method for simple, rapid and inexpensive analysis of drugs such as nicotine and other drugs which are accumulated in biological samples of addictive drugger of tobacco, stimulant drug and the like. The method comprises the steps of introducing the biological sample into an injection needle, inserting the needle into an injector of a chromatograph and injecting a carrier into the needle to conduct chromatography treatment.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: August 4, 2015
    Assignees: SHINWA CHEMICAL INDUSTRIES, LTD., NATIONAL UNIVERSITY CORPORATION TOYOHASHI UNIVERSITY OF TECHNOLOGY, NIPPON MEDICAL SCHOOL FOUNDATION
    Inventors: Hiroo Wada, Kiyokatsu Jinno, Yoshihiro Saito, Youkichi Ohno, Makiko Hayashida
  • Patent number: 9096847
    Abstract: Bioreactors comprising an electrical stimulation system supply a pulsed and/or modulated electrical input to microbes that use the electrical stimulation and available CO2 to produce valuable organic compounds. Electrical power, such as from renewable sources remotely located with respect to the power grid, can be converted to chemical energy in the form of the organic compounds, which can be stored and/or transported readily.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: August 4, 2015
    Assignee: Oakbio, Inc.
    Inventor: Brian Sefton
  • Patent number: 9090929
    Abstract: A medium for the growth of vancomycin-resistant Enterococci comprising:— (i) a nutrient medium with an energy source effective to support growth and reproduction of vancomycin-resistant Enterococci; (ii) an effective amount of one or more selective agents to inhibit the growth of microorganisms other than vancomycin-resistant Enterococci; (iii) a Krebs cycle intermediate.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: July 28, 2015
    Assignee: Oxoid Limited
    Inventors: Stephen Dimmer, Dagmara Klein
  • Patent number: 8980541
    Abstract: An evaluation and preservation solution for human and animal organs, tissues and parts thereof is described, wherein it comprises serum albumin at a concentration of 55-105 g/L, a scavenger and coating compound, preferably dextran compounds and derivatives thereof having essentially the same structure at a concentration of 1-55 g/L weight, and a physiological serum concentration of salts and nutrients in a physiologically acceptable medium.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: March 17, 2015
    Assignee: XVIVO Perfusion AB
    Inventor: Stig Steen
  • Patent number: 8927239
    Abstract: A process for improving the yield and efficiency of an ethanol fermentation plant that receives organic fermentable feedstock material, prepares the feedstock for fermentation, ferments the feedstock with yeast to produce ethanol, and produces stillage as a byproduct of ethanol fermentation. The process steps which can be operated independently or in combination, may include, but are not limited to, degrading fatty acids in the fermentable feedstock material prior to fermentation; degrading cellulose and hemicellulose present in the feedstock prior to fermentation; adding a surfactant to the fermentable feedstock; separating a liquid fraction from the stillage; recycling the liquid fraction to be combined with the fermentable feedstock; recovering a solid fraction from the stillage; and introducing at least a portion of the solid fraction to an anaerobic digester to produce methane.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: January 6, 2015
    Assignee: Water Solutions, Inc.
    Inventors: Stephen D. Allen, Michael R. Rusnack
  • Patent number: 8927234
    Abstract: It is intended to provide a simple method for producing hyaluronic acid at a high yield. Further, it is also intended to provide a method for producing hyaluronic acid in a short period of time. The invention provides a method for producing hyaluronic acid including a step of culturing a microorganism having the capability to produce hyaluronic acid and a step of adding glutamine and arginine to a culture medium during late logarithmic growth phase of the microorganism.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: January 6, 2015
    Assignee: Denki Kagaku Kogyo Kabushiki Kaisha
    Inventors: Masamichi Hashimoto, Teruaki Kakema, Kenji Fujii, Masahisa Ikemi
  • Patent number: 8883472
    Abstract: A method for extracting water from an aqueous solution of a protein comprising the steps of: (a) intermixing the aqueous solution of the protein with a sufficient quantity of at least one glycol ether at a temperature at least 30 centigrade degrees above the lower critical solution temperature (LCST), preferably at least 20 centigrade degrees above the LCST, and most preferably at least 10 degrees above the LCST, to form a suspension comprising a concentrated aqueous protein phase and a liquid organic phase comprising said at least one glycol ether and at least 10 percent water extracted from the aqueous solution of the protein, wherein the glycol ether has an inverse solubility in water, with the proviso that the solubility of the glycol ether in water is significantly less than the solubility of water in the glycol ether, and the glycol ether does not significantly deactivate the protein, and (b) separating the concentrated aqueous protein phase formed in step (a) from at least a portion of the liquid orga
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: November 11, 2014
    Assignee: Dow AgroSciences, LLC.
    Inventors: Felipe A. Donate, Timothy C. Frank, Barbara J. Grabowski